Vijay Kumar Prajapati (Vijay K Prajapati, Vijay Prajapati)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 22

Top Venues

Journal of biomolecular structure & dynamics

Journal of cellular physiology

Journal of cellular biochemistry

Molecular diversity

Central University of Rajasthan

Banaras Hindu University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Central University of Rajasthan

India

Assistant Professor :: Biochemistry

Education History

Banaras Hindu University

India

MSC :: Biochemistry

Publications

Rupal Ojha, Satyendra Singh, Nidhi Gupta, Ketan Kumar, Aditya K Padhi, Vijay Kumar Prajapati
Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections. Biotechnology letters (2023)
Rupal Ojha, Satyendra Singh, Nidhi Gupta, Ketan Kumar, Aditya K Padhi, Vijay Kumar Prajapati
Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections. Biotechnology letters (2023)
Satyendra Singh, Vijay Kumar Prajapati
Exploring actinomycetes natural products to identify potential multi-target inhibitors against Leishmania donovani . 3 Biotech 12 (9) (2022)
Mamta Panda, Elora Kalita, Satyendra Singh, Ketan Kumar, Vijay Kumar Prajapati
Nanobody-peptide-conjugate (NPC) for passive immunotherapy against SARS-CoV-2 variants of concern (VoC): a prospective pan-coronavirus therapeutics. Molecular diversity (2022)
Satyendra Singh, Priya Chauhan, Vinita Sharma, Abhishek Rao, Bajarang Vasant Kumbhar, Vijay Kumar Prajapati
Identification of multi-targeting natural antiviral peptides to impede SARS-CoV-2 infection. Structural chemistry (2022)
Satyendra Singh, Ketan Kumar, Mamta Panda, Aryan Srivastava, Amit Mishra, Vijay Kumar Prajapati
High-throughput virtual screening of small-molecule inhibitors targeting immune cell checkpoints to discover new immunotherapeutics for human diseases. Molecular diversity (2022)
Satyendra Singh, Priya Chauhan, Vinita Sharma, Abhishek Rao, Bajarang Vasant Kumbhar, Vijay Kumar Prajapati
Identification of multi-targeting natural antiviral peptides to impede SARS-CoV-2 infection. Structural chemistry (2022)
Arun Upadhyay, Ayeman Amanullah, Vibhuti Joshi, Rohan Dhiman, Vijay Kumar Prajapati, Krishna Mohan Poluri, Amit Mishra
Ibuprofen-based advanced therapeutics: breaking the inflammatory link in cancer, neurodegeneration, and diseases. Drug metabolism reviews 53 (1) (2021)
Prashant Kumar, Yuvraj Anandrao Jagtap, Som Mohanlal Patwa, Sumit Kinger, Ankur Rakesh Dubey, Vijay Kumar Prajapati, Rohan Dhiman, Krishna Mohan Poluri, Amit Mishra
Autophagy based cellular physiological strategies target oncogenic progression. Journal of cellular physiology (2021)
Utkarsha Sahu, Debasis Biswas, Vijay Kumar Prajapati, Anirudh K Singh, Mukesh Samant, Prashant Khare
Interleukin-17-A multifaceted cytokine in viral infections. Journal of cellular physiology (2021)
Biswajit Naik, Venkata Satish Kumar Mattaparthi, Nidhi Gupta, Rupal Ojha, Pundarikaksha Das, Satyendra Singh, Vijay Kumar Prajapati, Dhaneswar Prusty
Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications. Journal of biomolecular structure & dynamics (2021)
Vikrant Singh Rajput, Ritika Sharma, Anchala Kumari, Nidhi Vyas, Vijay Kumar Prajapati, Abhinav Grover
Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins. Journal of biomolecular structure & dynamics (2021)
Rupal Ojha, Vijay Kumar Prajapati
Cognizance of posttranslational modifications in vaccines: A way to enhanced immunogenicity. Journal of cellular physiology (2021)
Vinita Sharma, Priya Chouhan, Rajan Kumar Pandey, Rupal Ojha, Veeranarayanan Surya Aathmanathan, Muthukalingan Krishnan, Vijay Kumar Prajapati
Immunoglobulin interface redesigning to enhance lebrikizumab mediated immunomodulation of IL-13 hyper-response. Journal of biomolecular structure & dynamics 39 (11) (2020)
Banoth Karan Kumar, Faheem Faheem, Kondapalli Venkata Gowri Chandra Sekhar, Rupal Ojha, Vijay Kumar Prajapati, Aravinda Pai, Sankaranarayanan Murugesan
Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases. Journal of biomolecular structure & dynamics (2020)
Preeti Rana Sirohi, Jyoti Gupta, Pallavi Somvanshi, Vijay Kumar Prajapati, Abhinav Grover
Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein. Journal of biomolecular structure & dynamics (2020)
Nidhi Gupta, Nazia Khatoon, Amit Mishra, Vijay Kumar Verma, Vijay Kumar Prajapati
Structural vaccinology approach to investigate the virulent and secretory proteins of Bacillus anthracis for devising anthrax next-generation vaccine. Journal of biomolecular structure & dynamics 38 (16) (2019)
Rupal Ojha, Raj Nandani, Vijay Kumar Prajapati
Contriving multiepitope subunit vaccine by exploiting structural and nonstructural viral proteins to prevent Epstein-Barr virus-associated malignancy. Journal of cellular physiology 234 (5) (2018)
Rajan Kumar Pandey, Vijay Kumar Prajapati
Exploring sand fly salivary proteins to design multiepitope subunit vaccine to fight against visceral leishmaniasis. Journal of cellular biochemistry (2018)
Rajan Kumar Pandey, Rupal Ojha, Amit Mishra, Vijay Kumar Prajapati
Designing B- and T-cell multi-epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection. Journal of cellular biochemistry 119 (9) (2018)
Nazia Khatoon, Rajan Kumar Pandey, Rupal Ojha, Veeranarayanan Surya Aathmanathan, Muthukalingan Krishnan, Vijay Kumar Prajapati
Exploratory algorithm to devise multi-epitope subunit vaccine by investigating Leishmania donovani membrane proteins. Journal of biomolecular structure & dynamics 37 (9) (2018)
Rajan K Pandey, Rupal Ojha, Nina Chatterjee, Nitesh Upadhyay, Amit Mishra, Vijay Kumar Prajapati
Combinatorial screening algorithm to engineer multiepitope subunit vaccine targeting human T-lymphotropic virus-1 infection. Journal of cellular physiology 234 (6) (2018)

Vijay Kumar Prajapati.css-eqlu8i{font-size:small;padding-left:4px;} (Vijay K Prajapati, Vijay Prajapati)

Publication Activity (10 Years)

Top Topics

Top Venues

Vijay Kumar Prajapati (Vijay K Prajapati, Vijay Prajapati)